Drugs, Biologics, and Medical Devices: A Compendium
This Compendium includes a wealth of reports on drugs, biologics and medical devices. The reports included consist of the authority to regulate drug compounding; the law and intellectual property rights of biologics; federal drug discovery and pricing; the FDA’s Safety and Innovation ACT (P.L. 112-114); effects on pharmaceutical innovation and effects of generic brands; infringement and experimental use under the Hatch-Waxman Act. Furthermore, the reauthorization of the Prescription Drug User Fee Act (PDUFA); and how the FDA approves drugs and regulates their safety and effectiveness.
THE DOCUMENT INCLUDES FOLLOWING FILES:
|#||FILE NAME||Document Date||Order ID:||Number of Pages||PRICE|
|1||C-12010 Drugs Biologics and Medical Devices C-12010.pdf||Feb 04, 2013||C12010||313||$79.95||ADD TO CART|